110099-99-5

Basic information

• Product Name: 5-Pyrimidinecarbonyl chloride, 2-chloro- (9CI)
• Synonyms: 5-Pyrimidinecarbonyl chloride, 2-chloro- (9CI);2-Chloro-5-pyrimidinecarbonyl chloride, 95%
• CAS NO: 110099-99-5
• Molecular Formula: C₅H₂Cl₂N₂O
• Molecular Weight: 176.98818
• Product Categories: ACIDHALIDE
• Mol File: 110099-99-5.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 315.7±15.0 °C(Predicted)
• Appearance: White to yellow/Powder or Low Melting Solid
• Density: 1.549±0.06 g/cm3(Predicted)
• PKA: -3.67±0.22(Predicted)
• CAS DataBase Reference: 5-Pyrimidinecarbonyl chloride, 2-chloro- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Pyrimidinecarbonyl chloride, 2-chloro- (9CI)(110099-99-5)
• EPA Substance Registry System: 5-Pyrimidinecarbonyl chloride, 2-chloro- (9CI)(110099-99-5)

Safety Data

• Hazardous Substances Data: 110099-99-5(Hazardous Substances Data)

Usage

General Description

5-Pyrimidinecarbonyl chloride, 2-chloro- (9CI) is a chemical compound that is used in organic synthesis as a reactive intermediate in the production of pharmaceuticals, agrochemicals, and various other fine chemicals. It is a white to yellow solid with a pungent odor and is highly reactive, especially towards water and moisture. The compound is primarily used as an acylating agent in the synthesis of pyrimidine derivatives and as a building block for various heterocyclic compounds. It is important to handle this compound with caution as it is corrosive and can cause irritation to the skin, eyes, and respiratory system. Furthermore, it should be stored and handled in a well-ventilated area and with appropriate protective equipment.

Upstream product

• 38324-83-3 2-oxo-1,2-dihydropyrimidine-5-carboxylic acid 
• 374068-01-6 2-bromopyrimidine-5-carboxylic acid 
• 95928-49-7 ethyl 2-oxo-1,2-dihydropyrimidine-5-carboxylate 
• 33458-27-4 ethyl 2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate 
• 89793-12-4 ethyl 2-chloropyrimidine-5-carboxylate 
• 73781-88-1 ethyl 2-(methylthio)pyrimidine-5-carboxylate 
• 38324-83-3 2-hydroxypyrimidine-5-carboxylic acid 

Downstream Products

• 110100-02-2 (2-chloropyrimidin-5-yl)(phenyl)methanone 
• 1753-50-0 2-chloropyrimidine-5-carbonitrile 
• 1213234-72-0 (5-{2-[1-(3,4,5-Trichlorobenzyl)-1H-1,2,3-triazol-4-yl]pyrimidin-5-yl}-2H-tetrazol-2-yl)acetic acid 
• 856595-94-3 2-chloropyrimindine-5-carboxaminde 
• 1213234-96-8 5-(2H-tetrazol-5-yl)-2-[1-(3,4,5-trichlorobenzyl)-1H-1,2,3-triazol-4-yl]pyrimidine 
• 1213234-97-9 ethyl (5-{2-[1-(3,4,5-trichlorobenzyl)-1H-1,2,3-triazol-4-yl]pyrimidin-5-yl}-2H-tetrazol-2-yl)acetate 
• 1360443-21-5 2-chloro-N-methylpyrimidine-5-carboxamide 
• 1240496-04-1 2-mercapto-pyrimidine-5-carboxylic acid (4-fluoro-phenyl)-amide 
• 1648843-04-2 {2-[({5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl}sulfanyl)methyl]-4-(trifluoromethoxy)phenyl}boronic acid 
• 1360598-99-7 2-chloro-pyrimidine-5-carboxylic acid (4-fluoro-phenyl)-amide 
• 110100-07-7 1-benzyl-5-pentanoyl-2(1H)-pyrimidinone 
• 110100-00-0 1-(2-chloropyrimidin-5-yl)ethan-1-one 
• 110100-09-9 2-(2-chloropyrimidin-5-yl)propan-2-ol 

Relevant articles and documents

6-5 FUSED RINGS AS C5a INHIBITORS

The present disclosure provides, inter alia, Compounds of Formula (I) (I) or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.

Effective combinatorial immunotherapy for castration-resistant prostate cancer

A significant fraction of patients with advanced prostate cancer treated with androgen deprivation therapy experience relapse with relentless progression to lethal metastatic castration-resistant prostate cancer (mCRPC). Immune checkpoint blockade using a

HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Heteroaromatic compounds of structural formula I are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and tr